How does a myocardial bridge cause chest pain?

How Myocardial Bridge Causes Chest Pain

Myocardial bridges cause chest pain through multiple distinct mechanisms: systolic compression of the tunneled coronary artery that extends into diastole during tachycardia (compromising coronary filling time), endothelial dysfunction leading to epicardial vasospasm, and coexisting coronary microvascular dysfunction—all of which can produce myocardial ischemia even when the bridge itself is not hemodynamically significant. 1, 2, 3

Primary Pathophysiological Mechanisms

Systolic Compression with Diastolic Extension

• The intramuscular coronary segment undergoes dynamic compression during systole as the overlying myocardial "bridge" contracts 3, 4
• During tachycardia (exercise, stress, or elevated adrenergic tone), this systolic compression extends into diastole, critically reducing coronary filling time and causing ischemia 5, 6
• The degree of compression is directly proportional to bridge depth and thickness, with deeper bridges (>5mm) correlating with recurrent angina 4, 5
• This is a dynamic phenomenon that worsens with physical exertion and emotional stress, explaining why symptoms are typically exertional 3, 7

Endothelial Dysfunction and Epicardial Vasospasm

• Repetitive systolic compression causes endothelial injury and dysfunction in the bridged segment 3, 7
• This endothelial damage triggers coronary vasospasm, which can occur even at rest and explains cases of unstable angina, myocardial infarction, and sudden cardiac death 3, 7
• Epicardial spasm occurs in 37% of patients with myocardial bridge and chest pain, regardless of whether the bridge is hemodynamically significant 2
• Transient spontaneous angina must be corroborated by reproducible narrowing during acetylcholine testing, which demonstrates spastic hyperactivity 6

Coronary Microvascular Dysfunction

• Endothelium-independent coronary microvascular dysfunction (coronary flow reserve <2.0 or index of microvascular resistance ≥25) occurs in 60% of patients with myocardial bridge and angina 2
• Microvascular spasm (chest pain with ECG changes but non-ischemic fractional flow reserve on acetylcholine testing) occurs in 29% of patients 2
• At least one of these microvascular abnormalities is present in 77% of symptomatic patients, independent of the hemodynamic significance of the bridge itself 2
• The 2024 ESC Guidelines recognize that structural abnormalities like myocardial bridging can cause transient ischemia through both macrovascular and microvascular mechanisms 1

Proximal Atherosclerosis Development

• Atherosclerotic plaques preferentially develop immediately proximal to the bridged segment due to altered shear stress, low wall shear stress, and high oscillatory flow patterns 4, 5
• Disrupted flow patterns (particularly flow recirculation) exacerbate LDL internalization, cell adhesion, and monocyte adhesion to the endothelium 5
• The compressed segment itself is typically spared from atherosclerosis, creating a characteristic pattern 4
• This proximal atherosclerosis can contribute to fixed obstructive disease and ischemia independent of the bridge compression 5

Clinical Manifestations

Symptom Patterns

• Exertional angina is the most common presentation, with symptoms building gradually over minutes (not instantaneously) 3, 5
• Symptoms are described as pressure, squeezing, gripping, heaviness, or tightness—rarely as sharp "pain" 8
• Radiation to neck, jaw, left arm, or interscapular region is characteristic 8
• Associated symptoms include dyspnea, diaphoresis, nausea, lightheadedness, or presyncope 8

Severe Presentations

• Unstable angina or acute coronary syndrome can occur when exceptionally prolonged and severe spasm induces intraluminal thrombosis 3, 6
• Ventricular arrhythmias and sudden cardiac death have been reported, likely due to ischemia-induced electrical instability 3, 4
• Myocardial stunning and takotsubo cardiomyopathy are recognized complications 5

Diagnostic Approach

Initial Evaluation

• Obtain 12-lead ECG within 10 minutes to identify ST-segment changes or T-wave inversions 8
• Measure high-sensitivity cardiac troponin immediately 8
• Nuclear myocardial scintigraphy is usually negative in patients with isolated myocardial bridging without coexisting disease 6

Anatomic Assessment

• Coronary computed tomography angiography identifies bridge location, depth, and length non-invasively 3, 6
• Intravascular ultrasound during catheterization confirms the intramuscular course and measures bridge thickness 4, 6

Hemodynamic and Functional Testing

• Dobutamine stress testing with resting full-cycle ratio measurement determines hemodynamic significance (≤0.76 indicates significant compression) 2
• Fractional flow reserve ≤0.80 or instantaneous wave-free ratio ≤0.89 during stress indicates pathological stenosis requiring treatment 5
• Acetylcholine provocation testing identifies epicardial spasm (>90% dynamic stenosis or ischemic FFR ≤0.8) and microvascular spasm (chest pain with ECG changes but non-ischemic FFR) 2, 6
• Adenosine testing measures coronary flow reserve and index of microvascular resistance to diagnose endothelium-independent microvascular dysfunction 2

Critical Clinical Pitfalls

• Do not assume myocardial bridge is benign based solely on angiographic appearance—77% of symptomatic patients have coexisting epicardial spasm, microvascular spasm, or microvascular dysfunction that explains symptoms 2
• Hemodynamic significance of the bridge does not predict presence of other ischemic mechanisms—microvascular abnormalities occur equally in hemodynamically significant and non-significant bridges 2
• Nitroglycerin is contraindicated in isolated myocardial bridge because it can worsen symptoms by increasing heart rate and myocardial contractility, thereby worsening systolic compression 4, 7
• Beta-blocker monotherapy may worsen symptoms if coronary spasm is the dominant mechanism, requiring careful phenotyping before treatment 7, 6
• Normal epicardial coronary arteries on angiography do not exclude significant coronary disease—invasive coronary function testing is essential to uncover alternative explanations for angina 9, 2